Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

Topic: Cardi

Tuesday, 11 April 2017
Positive evidence for the benefits of the NHS Health Check has been published in the first report from the NHS Health Check Expert Scientific and Clinical Advisory Panel.
Category: Have You Heard
Monday, 17 July 2017
A new study has announced the new QRISK3 cardiovascular disease risk prediction algorithm. The calculator is used to work out the risk of developing a heart attack or stroke over the next 10 years. The risk calculator is designed for use in the UK.
Tuesday, 05 July 2016
Alirocumab (Praluent®) and evolocumab (Repatha®) have received final approval from NICE for the treatment of adults with primary hypercholesterolaemia or mixed dyslipidaemia to help reduce the risk of cardiovascular disease.
Category: Have You Heard
Friday, 13 May 2016
Alirocumab (Praluent) and evolocumab (Repatha) have been recommended by NICE for the treatment of adults with primary hypercholesterolaemia or mixed dyslipidaemia to help reduce the risk of cardiovascular disease.
Category: Have You Heard
Thursday, 02 February 2017

Offering smokers a taster session at an NHS Stop Smoking Service and explaining their personal risk of developing smoking-related diseases doubles their likelihood of attending a stop smoking course.

Friday, 02 August 2019

Community pharmacists are widely recognised as an under-utilised resource within the NHS, in spite of their skills and experience, and the accessibility of their premises. In recent years, community pharmacists have demonstrated the value of the clinical services they offer, particularly in the prevention of cardiovascular disease (CVD).

Category: Editorial
Thursday, 08 August 2019

In 2017 the University of Sheffield was commissioned by Public Health England (PHE) to develop a new return on investment (ROI) tool for cardiovascular disease (CVD) prevention, to be used by national and local decision-makers. The tool focuses on prevention of CVD in six key high-risk groups, identified through the NHS RightCare pathway as being currently underdiagnosed and insufficiently well managed. This includes patients with hypertension, diabetes (type 1 and type 2), non-diabetic hyperglycaemia, atrial fibrillation, chronic kidney disease and high cholesterol (the latter including patients with a QRISK2 score ≥ 10% or familial hypercholesterolaemia).

Category: Editorial
Monday, 12 September 2016

Chronic Obstructive Pulmonary Disease (COPD) has a major impact on the health and quality of life of patients and there is often co-morbidity with cardiovascular disease. Well planned and structured training for the primary care team could have a major impact on outcomes.

Category: Editorial
Sunday, 12 March 2017

A new study questions the feasibility and value of primary care screening for peripheral arterial disease (PAD). The PIPETTE study is the first UK study of PAD prevalence for nearly a decade.

Friday, 13 May 2016

Dr Matt Kearney, the new national clinical director for Cardiovascular Disease Prevention sets out his vision for cardiovascular disease (CVD) prevention in primary care.

Category: Have You Heard

Article search and filter